$0.616
+0.005 (+0.85%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LAB Prediction & Forecast by Similar Chart Analysis
Alphio's LAB stock price prediction model matches the current Standard BioTools Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.62 (+1.01%). The 1-week path is $0.64 (+4.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Standard BioTools Inc Stock?
Standard BioTools Inc (LAB) appears to be a good buy right now, primarily due to its current price of 0.6099, which is near its 52-week low of 0.59, indicating a potential for recovery. Additionally, the stock has a forward P/E ratio of 0, suggesting that it may be undervalued compared to its earnings potential. The recent merger with Treeline Biosciences is expected to enhance financial stability, providing over $900 million in cash to fund operations into 2029, which is a strong positive catalyst.
LAB stock price ended at $0.62 on Wednesday, after rising +0.85%
Standard BioTools Inc (LAB) last closed at $0.616, gaining +0.85%. These facts feed the 1-day and 1-week LAB price prediction above.
Forecast Drivers
Standard BioTools Inc (LAB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LAB, ranked by similarity.
Seasonality analysis for LAB
Historically the probability of a positive November return for LAB is 4.76%. January offers the highest probability of a positive month at 63.93%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for LAB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.46 | $1.72 | $2.08 | +178.55% |
| Dec 2026 | $1.02 | $1.46 | $1.51 | +136.73% |
In 2026, Standard BioTools Inc (LAB) is projected to range from $1.02 to $2.08.
Standard BioTools Inc 2026 monthly forecast
In Nov 2026, Standard BioTools Inc is projected to average $1.72, with a low of $1.46 and high of $2.08.
In Dec 2026, Standard BioTools Inc is projected to average $1.46, with a low of $1.02 and high of $1.51.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.